137 related articles for article (PubMed ID: 17471022)
1. Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter.
Lu S; Wang X; Xiao L; Cai L; Zhang Y; Wang H; Wang Z
Cancer Biol Ther; 2007 Mar; 6(3):397-404. PubMed ID: 17471022
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.
Wang Z; Cai L; Wang H
Gynecol Oncol; 2005 Mar; 96(3):643-50. PubMed ID: 15721406
[TBL] [Abstract][Full Text] [Related]
3. [Killing effect of adenovirus mediated fusion gene cytosine and deaminase uracil phosphoribosyl transferase directed by glutathione S-transferase P1 promoter on cisplatin-resistant ovarian cancer cells in vitro].
Cai LQ; Li M; Lu S; Wang HB; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):478-81. PubMed ID: 15347473
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo.
Lu S; Huang Q; Wang Z; Song Y; Wang L
J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):620-4. PubMed ID: 19821097
[TBL] [Abstract][Full Text] [Related]
5. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
[No Abstract] [Full Text] [Related]
6. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy for ovarian cancer by adenovirus-mediated transduction of cytosine deaminase gene in vitro].
Li Q; Peng Z; Wang H; Yao Y; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):5-8. PubMed ID: 15600165
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S
Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated double suicide gene selectively kills gastric cancer cells.
Luo XR; Li JS; Niu Y; Miao L
Asian Pac J Cancer Prev; 2012; 13(3):781-4. PubMed ID: 22631647
[TBL] [Abstract][Full Text] [Related]
12. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
[TBL] [Abstract][Full Text] [Related]
13. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
[TBL] [Abstract][Full Text] [Related]
14. Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.
Rein DT; Volkmer A; Bauerschmitz G; Beyer IM; Janni W; Fleisch MC; Welter AK; Bauerschlag D; Schöndorf T; Breidenbach M
J Cancer Res Clin Oncol; 2012 Apr; 138(4):603-10. PubMed ID: 22209976
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
16. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
17. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
18. [Role and mechanism of the regulation of nuclear factor-κB by heparin binding-epidermal growth factor-like growth factor in the induction of paclitaxel resistance of ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):255-261. PubMed ID: 31006192
[No Abstract] [Full Text] [Related]
19. Bystander effect from cytosine deaminase and uracil phosphoribosyl transferase genes in vitro: a partial contribution of gap junctions.
Tanaka T; Duflot-Dancer A; Tiraby M; Piccoli C; Tiraby G; Yamasaki H; Mesnil M
Cancer Lett; 2009 Sep; 282(1):43-7. PubMed ID: 19342154
[TBL] [Abstract][Full Text] [Related]
20. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
